Solid Biosciences Inc. (SLDB) Financials

SLDB Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 422.9 million 48.8 million
Dec. 31, 2025 232.5 million 52.5 million
Sept. 30, 2025 273.9 million 56.0 million
June 30, 2025 308.3 million 50.0 million

SLDB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -47.4 million 5.2 million
Dec. 31, 2025 -54.1 million 6.5 million
Sept. 30, 2025 -33.6 million 3.9 million
June 30, 2025 -37.8 million 3.1 million

SLDB Net Income

No data available :(

SLDB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 381.3 million - 18.5 million
Dec. 31, 2025 189.1 million - 19.1 million
Sept. 30, 2025 236.1 million - 21.9 million
June 30, 2025 268.1 million - 23.1 million

SLDB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 109.8 million
Dec. 31, 2025 94.7 million
Sept. 30, 2025 94.4 million
June 30, 2025 94.1 million

SLDB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 165000 46.1 million 11.2 million -
Dec. 31, 2025 565000 38.1 million 11.3 million -
Sept. 30, 2025 85000 38.9 million 9.2 million -
June 30, 2025 377000 32.4 million 9.3 million -

SLDB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 395000
Dec. 31, 2025 - 467000
Sept. 30, 2025 - 376000
June 30, 2025 - 386000

SLDB

Price: $7.83

52 week price:
3.79
11.45

Earnings Per Share: -1.92 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 27300

Market Capitalization: 857.0 million

Links: